Citadel Advisors - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 64 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$23,850
+32.9%
15,900
-36.5%
0.00%
Q1 2023$17,950
-63.8%
25,021
-70.8%
0.00%
Q4 2022$49,616
-13.0%
85,618
+41.9%
0.00%
Q3 2022$57,000
-44.1%
60,340
-28.6%
0.00%
Q2 2022$102,000
-64.2%
84,478
-61.1%
0.00%
Q1 2022$285,000
-76.7%
217,170
-68.8%
0.00%
Q4 2021$1,225,000
-9.3%
695,482
+11.7%
0.00%
Q3 2021$1,351,000
-60.1%
622,518
-35.7%
0.00%
Q2 2021$3,386,000
-69.2%
967,519
-13.2%
0.00%
-100.0%
Q1 2021$10,984,000
+7.2%
1,114,016
+17.8%
0.00%
+50.0%
Q4 2020$10,250,000
+91.2%
945,523
+81.6%
0.00%
+100.0%
Q3 2020$5,362,000
-73.0%
520,544
-45.2%
0.00%
-85.7%
Q2 2020$19,839,000
+69.8%
950,130
-20.5%
0.01%
+40.0%
Q1 2020$11,681,000
+218.5%
1,195,544
+275.5%
0.01%
+400.0%
Q4 2019$3,668,000
-41.9%
318,360
-72.5%
0.00%
-50.0%
Q3 2019$6,318,000
+1108.0%
1,159,322
+2539.2%
0.00%
Q2 2019$523,000
+388.8%
43,927
+114.8%
0.00%
Q1 2019$107,000
-97.8%
20,450
-98.7%
0.00%
-100.0%
Q4 2018$4,773,000
-4.8%
1,515,207
+82.8%
0.00%
+50.0%
Q3 2018$5,014,000
-54.7%
828,851
-60.3%
0.00%
-60.0%
Q2 2018$11,058,000
+36.9%
2,086,653
+49.8%
0.01%
+25.0%
Q1 2018$8,077,000
+4795.2%
1,392,678
+2851.3%
0.00%
Q4 2017$165,000
+345.9%
47,189
+365.1%
0.00%
Q3 2017$37,000
-36.2%
10,147
-27.5%
0.00%
Q3 2016$58,00013,9970.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2023
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders